Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 525

1.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508.

PMID:
25537519
[PubMed - in process]
Free Article
2.

Clinical Impact of Regulatory T cells (Treg) in Cancer and HIV.

Whiteside TL.

Cancer Microenviron. 2014 Nov 12. [Epub ahead of print]

PMID:
25385463
[PubMed - as supplied by publisher]
3.

Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Szczepanski MJ, Luczak M, Olszewska E, Molinska-Glura M, Zagor M, Krzeski A, Skarzynski H, Misiak J, Dzaman K, Bilusiak M, Kopec T, Leszczynska M, Witmanowski H, Whiteside TL.

J Mol Med (Berl). 2014 Nov 12. [Epub ahead of print]

PMID:
25385222
[PubMed - as supplied by publisher]
4.

Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.

Spitler LE, Cao H, Piironen T, Whiteside TL, Weber RW, Cruickshank S.

Am J Clin Oncol. 2014 Oct 3. [Epub ahead of print]

PMID:
25286079
[PubMed - as supplied by publisher]
5.

Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia.

Hong CS, Muller L, Boyiadzis M, Whiteside TL.

PLoS One. 2014 Aug 5;9(8):e103310. doi: 10.1371/journal.pone.0103310. eCollection 2014.

PMID:
25093329
[PubMed - in process]
Free PMC Article
6.

Isolation of biologically-active exosomes from human plasma.

Muller L, Hong CS, Stolz DB, Watkins SC, Whiteside TL.

J Immunol Methods. 2014 Sep;411:55-65. doi: 10.1016/j.jim.2014.06.007. Epub 2014 Jun 18.

PMID:
24952243
[PubMed - indexed for MEDLINE]
7.

Measurements of natural killer (NK) cells.

Butterfield LH, Whiteside TL.

Crit Rev Oncog. 2014;19(1-2):47-55. Review.

PMID:
24941372
[PubMed - indexed for MEDLINE]
8.

Induced regulatory T cells in inhibitory microenvironments created by cancer.

Whiteside TL.

Expert Opin Biol Ther. 2014 Oct;14(10):1411-25. doi: 10.1517/14712598.2014.927432. Epub 2014 Jun 17.

PMID:
24934899
[PubMed - in process]
9.

Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.

Pollack IF, Jakacki RI, Butterfield LH, Hamilton RL, Panigrahy A, Potter DM, Connelly AK, Dibridge SA, Whiteside TL, Okada H.

J Clin Oncol. 2014 Jul 1;32(19):2050-8. doi: 10.1200/JCO.2013.54.0526. Epub 2014 Jun 2.

PMID:
24888813
[PubMed - indexed for MEDLINE]
10.

Immunoregulatory activity of adenosine and its role in human cancer progression.

Muller-Haegele S, Muller L, Whiteside TL.

Expert Rev Clin Immunol. 2014 Jul;10(7):897-914. doi: 10.1586/1744666X.2014.915739. Epub 2014 May 29.

PMID:
24871693
[PubMed - in process]
11.

Plasma exosomes as markers of therapeutic response in patients with acute myeloid leukemia.

Hong CS, Muller L, Whiteside TL, Boyiadzis M.

Front Immunol. 2014 Apr 10;5:160. doi: 10.3389/fimmu.2014.00160. eCollection 2014.

PMID:
24782865
[PubMed]
Free PMC Article
12.

Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells.

Schuler PJ, Saze Z, Hong CS, Muller L, Gillespie DG, Cheng D, Harasymczuk M, Mandapathil M, Lang S, Jackson EK, Whiteside TL.

Clin Exp Immunol. 2014 Aug;177(2):531-43. doi: 10.1111/cei.12354.

PMID:
24749746
[PubMed - indexed for MEDLINE]
13.

Phase I dendritic cell p53 peptide vaccine for head and neck cancer.

Schuler PJ, Harasymczuk M, Visus C, Deleo A, Trivedi S, Lei Y, Argiris A, Gooding W, Butterfield LH, Whiteside TL, Ferris RL.

Clin Cancer Res. 2014 May 1;20(9):2433-44. doi: 10.1158/1078-0432.CCR-13-2617. Epub 2014 Feb 28.

PMID:
24583792
[PubMed - in process]
14.

Exosomes in Plasma of Patients with Ovarian Carcinoma: Potential Biomarkers of Tumor Progression and Response to Therapy.

Szajnik M, Derbis M, Lach M, Patalas P, Michalak M, Drzewiecka H, Szpurek D, Nowakowski A, Spaczynski M, Baranowski W, Whiteside TL.

Gynecol Obstet (Sunnyvale). 2013 Apr 29;Suppl 4:3.

PMID:
24466501
[PubMed]
Free PMC Article
15.

Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

Whiteside TL.

Cancer Immunol Immunother. 2014 Jan;63(1):67-72. doi: 10.1007/s00262-013-1490-y. Epub 2013 Nov 10. Review.

PMID:
24213679
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.

Jie HB, Gildener-Leapman N, Li J, Srivastava RM, Gibson SP, Whiteside TL, Ferris RL.

Br J Cancer. 2013 Nov 12;109(10):2629-35. doi: 10.1038/bjc.2013.645. Epub 2013 Oct 29.

PMID:
24169351
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Effects of adjuvant chemoradiotherapy on the frequency and function of regulatory T cells in patients with head and neck cancer.

Schuler PJ, Harasymczuk M, Schilling B, Saze Z, Strauss L, Lang S, Johnson JT, Whiteside TL.

Clin Cancer Res. 2013 Dec 1;19(23):6585-96. doi: 10.1158/1078-0432.CCR-13-0900. Epub 2013 Oct 4.

PMID:
24097865
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Generation and immunosuppressive functions of p53-induced human adaptive regulatory T cells.

Mandapathil M, Visus C, Finn OJ, Lang S, Whiteside TL.

Oncoimmunology. 2013 Jul 1;2(7):e25514. Epub 2013 Jul 3.

PMID:
24073385
[PubMed]
Free PMC Article
19.

CD4⁺CD73⁺ T cells are associated with lower T-cell activation and C reactive protein levels and are depleted in HIV-1 infection regardless of viral suppression.

Schuler PJ, Macatangay BJ, Saze Z, Jackson EK, Riddler SA, Buchanan WG, Hilldorfer BB, Mellors JW, Whiteside TL, Rinaldo CR.

AIDS. 2013 Jun 19;27(10):1545-55. doi: 10.1097/QAD.0b013e328360c7f3.

PMID:
24005375
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?

Szczepanski MJ, Whiteside TL.

Biomark Med. 2013 Aug;7(4):575-8. doi: 10.2217/bmm.13.68. No abstract available.

PMID:
23905893
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk